Seattle-based Mirador Biomedical has a veteran of Arrow International, a medical device company now part of Teleflex (NYSE: [[ticker:TFX]]) as its vice president of sales. Steve Gappa will take on that key role in commercializing Mirador’s Compass family of medical devices. Mirador won FDA approval last October for a digital device that can tell whether a healthcare professional is hitting a vein or an artery with a syringe, which is supposed to help avert dangerous bleeding episodes in the hospital. Mirador won FDA clearance for a second technology, which monitors pressure for lumbar puncture, last month.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
